Home > Quotes > RGLS
RGLS

Regulus Therapeutics Inc. Common Stock Quote & Summary Data

$5.84
*  
0.32
5.19%
Get RGLS Alerts
*Delayed - data as of Apr. 29, 2016  -  Find a broker to begin trading RGLS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Regulus Therapeutics Inc. Common Stock Intraday Chart




News for RGLS

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 6.32 $ 14.50
Low $ 5.7692 $ 5.14

The current last sale of $5.84 is 13.62% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

We are a biopharmaceutical company focused on discovering and developing first-in-class drugs that target microRNAs to treat a broad range of diseases. We were formed in 2007 when Alnylam Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc.(formerly Isis Pharmaceuticals, Inc.) contributed significant intellectual property, know-how and financial and human capital to pursue the development of drugs targeting microRNAs pursuant to a license and collaboration agreement. We have established strategic alliances with AstraZeneca AB and Sanofi to discover, develop and commercialize microRNA therapeutics. microRNAs are naturally occurring ribonucleic acid, or RNA, molecules that play a critical role in regulating key biological pathways. Scientific research has shown that the improper balance, or dysregulation, of microRNAs is directly linked to many diseases.  ... More ...  

Risk Grade

Where does RGLS fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?